BioSpace News Archive

Press Releases

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

October 30, 2025
·
1 min read
Press Releases

ENHERTU® approved in Canada as the first and only HER2-directed therapy for patients with HR-positive HER2-low or HER2-ultralow metastatic breast cancer, following disease progression after one or more endocrine therapies

October 30, 2025
·
9 min read
Press Releases

Curve Biosciences Raises $40 Million to Bring Whole-Body Intelligence to Chronic Disease Monitoring

October 30, 2025
·
3 min read
Press Releases

Rarity PBC Raises $4.6 Million Seed Financing to Advance Gene Therapy for ADA-SCID

October 30, 2025
·
4 min read
Press Releases

Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin

October 30, 2025
·
5 min read
Press Releases

PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer

October 30, 2025
·
7 min read
Press Releases

PolarityBio Announces Acceptance of Category III CPT® Code Application for Autologous Heterogeneous Skin Construct Graft by AMA CPT® Editorial Panel

October 30, 2025
·
2 min read
Press Releases

ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology

October 30, 2025
·
7 min read
Press Releases

PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025

October 30, 2025
·
3 min read
Press Releases

Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics

October 30, 2025
·
2 min read